Staurosporine

Staurosporine

Identifiers
IUPAC name (9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro- 10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy- 1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7] benzodiazonin-1-one
CAS Number	62996-74-1
PubChem CID	5280487
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C28H26N4O3
Molar mass	466.53 g/mol

WikiDoc Resources for Staurosporine
Articles
Most recent articles on Staurosporine Most cited articles on Staurosporine Review articles on Staurosporine Articles on Staurosporine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Staurosporine Images of Staurosporine Photos of Staurosporine Podcasts & MP3s on Staurosporine Videos on Staurosporine
Evidence Based Medicine
Cochrane Collaboration on Staurosporine Bandolier on Staurosporine TRIP on Staurosporine
Clinical Trials
Ongoing Trials on Staurosporine at Clinical Trials.gov Trial results on Staurosporine Clinical Trials on Staurosporine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Staurosporine NICE Guidance on Staurosporine NHS PRODIGY Guidance FDA on Staurosporine CDC on Staurosporine
Books
Books on Staurosporine
News
Staurosporine in the news Be alerted to news on Staurosporine News trends on Staurosporine
Commentary
Blogs on Staurosporine
Definitions
Definitions of Staurosporine
Patient Resources / Community
Patient resources on Staurosporine Discussion groups on Staurosporine Patient Handouts on Staurosporine Directions to Hospitals Treating Staurosporine Risk calculators and risk factors for Staurosporine
Healthcare Provider Resources
Symptoms of Staurosporine Causes & Risk Factors for Staurosporine Diagnostic studies for Staurosporine Treatment of Staurosporine
Continuing Medical Education (CME)
CME Programs on Staurosporine
International
Staurosporine en Espanol Staurosporine en Francais
Business
Staurosporine in the Marketplace Patents on Staurosporine
Experimental / Informatics
List of terms related to Staurosporine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Staurosporine (antibiotic AM-2282) is a natural product originally isolated in 1977 from bacterium Streptomyces staurosporeus. It was the first of over 50 alkaloids to be isolated with this type of bis-indole chemical structure. The chemical structure of staurosporine was elucidated by X-ray analysis of a single crystal and the absolute stereochemical configuration by the same method in 1994.

Staurosporine was discovered to have biological activities ranging from anti-fungal to anti-hypertensive. The interest in these activities resulted in a large investigative effort in chemistry and biology and the discovery of the potential for anti-cancer treatment.

The main biological activity of staurosporine is the inhibition of protein kinases through the prevention of ATP binding to the kinase. This is achieved through the stronger affinity of staurosporine to the ATP-binding site on the kinase.